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Abstract. Background: The Interleukin-1 (IL-1) signaling 
component TAK1 binding protein 2 (TAB2) plays a role in 
activating the NFkB and JNK signaling pathways. Addition-
ally, TAB2 functions in the nucleus as a repressor of NFkB-
mediated gene regulation.
Objective: To obtain insight into the function of TAB2 in 
the adult mouse, we analyzed the in vivo TAB2 expression 
pattern. 
Materials and methods: Cell lines and adult mouse tissues 
were analyzed for TAB2 protein expression and localiza-
tion. 
Results:  Immunohistochemical  staining  for  TAB2  protein 
revealed  expression  in  the  vascular  endothelium  of  most 
tissues, hematopoietic cells and brain cells. While TAB2 is 
localized in both the nucleus and the cytoplasm in cell lines, 
cytoplasmic localization predominates in hematopoietic tis-
sues in vivo.
Conclusions: The TAB2 expression pattern shows striking 
similarities with previously reported IL-1 receptor expres-
sion and NFkB activation patterns, suggesting that TAB2 in 
vivo is playing a role in these signaling pathways.
Key words:  TAB2 – Map3k7ip2 – NF-kappaB – Interleukin-1 –   
Hematopoiesis
Introduction
The cytokine Interleukin-1 (IL-1) is a well-known regulator 
within the hematopoietic system. IL-1 can act on several dif-
ferent hematopoietic cell types and plays a role in regulating 
their proliferation and differentiation, depending on the tar-
get cell and the presence of additional cytokines [1–3]. IL-1 
has also been shown to play a role in the migration and radio-
protection of immature hematopoietic cells [4, 5], indicating 
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its versatile role within the hematopoietic system. Moreover, 
IL-1 plays an important role in inflammatory reactions [6]. 
IL-1 is a potent inducer of fever and acute phase response 
in the adult [3] and importantly, IL-1 has been implicated 
in several inflammatory-related diseases, such rheumatoid 
arthritis, the neurodegenerative Alzheimer’s disease and in 
vascular diseases such as atherosclerosis [7–9]. 
The  regulation  of  these  different  biological  processes 
by IL-1 is mediated via signalling from the IL-1RI towards 
downstream signalling pathways, including the NFkB path-
way [6]. Signalling via NFkB members results in the regulat-
ed expression of various genes including those of cytokines 
and receptors involved in hematopoiesis and inflammation, 
as well as apoptosis and cell adhesion [10, 11]. NFkB signal-
ling induced by IL-1 in concert with other signals from the 
IL-1R and other cytokine receptors determines the biological 
outcome of the IL-1 induced response. 
Activation of the NFkB pathway by IL-1 is mediated via 
the transforming growth factor b (TGF-b) activated kinase 
1 (TAK1; also known as mitogen activated protein 3 kinase 
7 (MAP3K7)) together with three TAK1 binding proteins 
(TAB1, TAB2 and TAB3). TAB1 is a regulator of TAK1 
kinase activity and is widely expressed [12, 13]. TAB2 was 
originally reported as an adapter protein required for the re-
cruitment of TAK1 and TRAF6 to the IL-1 receptor. More 
recent studies showed that TAB2 plays a similar role in the 
LPS, Toll and TNF signaling pathways [14–16]. TAB3 is 
highly homologous to TAB2 and also functions as an adapter 
protein linking TAK1 to similar receptors as reported for 
TAB2 [15, 17, 18]. 
The role for TAB2 as an adapter protein has been ques-
tioned by more recent studies with TAB2 deficient cells and 
mice [19, 20]. Upon IL-1 stimulation, TAB2-deficient cells 
responded similarly to wildtype cells in the expression of IL-
1 target genes and the activation of the cytoplasmic JNK and 
NFkB signaling pathways.
Besides  its  role  as  a  TAK1  adapter  protein,  another 
role  for  TAB2  was  provided  by  studies  in  which  TAB2 
was  shown  to  act  as  modulator  of  NFkB-mediated  gene 
activation in the nucleus [21, 22]. Upon IL-1 stimulation, 
TAB2 was transported from the nucleus to the cytoplasm 
and TAB2-mediated repression of NFkB target genes was  Correspondence to: E. Dzierzak
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thereby  relieved. Altogether,  these  different  studies  show 
that TAB2 could be playing different roles in IL-1 receptor 
signaling and NFkB-mediated gene regulation depending on 
the subcellular localization of TAB2. 
Although the cellular pattern associated with IL-1 re-
ceptor expression and NFkB activation in the adult mouse 
tissues [23] is known, little information is available concern-
ing the expression pattern of TAB2 or the role it plays in 
physiological processes. As the expression pattern of TAB2 
could provide more insight into its in vivo role in IL-1 and 
NFkB  signaling,  we  studied  the  TAB2  expression  in  the 
adult mouse. Protein analysis revealed TAB2 expression in 
all adult tissues examined, with a distinctive spatial expres-
sion of TAB2 in brain, thymus and spleen.
Material and methods
Mice, cell enrichment and cell culture
Animals were housed according to institutional guidelines, with free 
access to water and food. Animal procedures were carried out in com-
pliance with the Standards for Humane Care and Use of Laboratory 
Animals. (CBAxC57/BL10)F1 mice used for these studies were sacri-
ficed by cervical dislocation and tissues collected in PBS/10 %FCS/1 % 
Pen/Strep.
Bone marrow and spleen cells were incubated with PE-conjugated 
anti-CD45 antibody (Pharmingen) for 20 min on ice, washed twice and 
resuspended in PBS/10 % FCS/1 % Pen/Strep and Hoechst 33258 (1 µg/
ml, Molecular Probes) for dead cell exclusion. Cells were sorted on a 
FACSAria (Becton Dickinson). To separate mature (lineage positive) 
and immature (lineage negative) BM fractions, hematopoietic cells were 
incubated with CD11b, CD5, Gr-1, Ter119, B220 (Pharmingen en Im-
munotech) followed by incubation with magnetic microbeads (Miltenyi 
Biotec). Lineage positive and negative cells were sorted on the autoM-
ACS system (Miltenyi Biotec).
3T3 fibroblasts were cultured in DMEM/10 % FCS/1 %PenStrep and 
CHO cells were cultured with Ham’s F10/10 %FCS/1 % PenStrep. Cells 
were transfected with either Lipofectamine 2000
TM (Life Technologies) 
or Fugene Transfection reagent
TM (Roche) according to manufacturer’s 
instructions and harvested 24–48 h after transfection. 
Generation of the HA-tagged mTAB2 constructs
The following primers were used to amplify the mouse TAB2 cDNA 
from  the  TAB2  IMAGE  clone  (3586132)  and  to  introduce  a  BglII 
restriction site upstream of the ATG-start codon: TAB2 forw 5´-AG-
ATCTATGGCCCAAGGAAGCCACC-3´  and  TAB2  rev  5´AGAAAT-
GCCGAGGCATCTCAC-3´.  The  mTAB2  cDNA  was  cloned  into 
PGEM-Teasy  vector
TM  (Promega)  and  confirmed  by  sequencing. 
mTAB2 was subcloned into the pBluescript vector
TM (Stratagene) and 
a HA-tag (a kind gift of D.Meier) was inserted in frame with the coding 
region of mTAB2 cDNA. Thereafter HA-mTAB2 was cloned into the 
pCDNA3
TM expression vector (Invitrogen) for overexpression studies. 
The N-terminally truncated mTAB2 construct was initially PCR-ampli-
fied from the mTAB2 IMAGE clone with the following primers TAB2-
1280 forw 5´-AGATCTATGCGGAATCAACCGACACTCTTC-3´ and 
TAB2  rev  5´AGAAATGCCGAGGCATCTCAC-3´  and  the  construct 
was generated in a similar manner as described above.
Western blotting
Protein lysates were made with RIPA lysis buffer or in Laemlli sample 
buffer. Protein lysates derived from an equivalent of 0.4–2 × 10
6 cells 
per tissue were separated on 7–10 % SDS-PAGE and blotted to PVDF 
membrane (Immobilon, Millipore). Blotted membranes were blocked 
with 4 % non-fat dry milk (Biorad)/ TBS-T and incubated overnight 
with primary antibody in 2 % milk/TBS-T, then incubated with HRP la-
beled secondary antibody and visualized by ECL detection. Antibodies 
used were TAB2 (against C-terminus, k-20; Tebu Bio), TAB2 (against 
C-terminus, PA1-853 Affinity BioReagents), a-HA (Santa Cruz), and 
anti-actin (Sigma).
Immunofluorescence and histochemistry
Adult tissues were snap-frozen and 7–10 µM cryosections were made. 
Sections were fixed in 2 % paraformaldehyde/PBS and incubated with 
primary antibody overnight at 4 °C. Staining was visualized with Santa 
Cruz or Vector Laboratories ABC staining kit in combination with TSA 
biotin system (PerkinElmer) according to provided instructions. Sec-
tions were counterstained with hematoxylin, dehydrated and embedded 
in Entallan. 
For immunostaining studies, cytospins of BM and spleen cells were 
made or cells were grown on gelatin-coated glass coverslips. Cells were 
fixed with 4 % paraformaldehyde and stained with above described an-
tibodies diluted in NETGEL (50 mM Tris pH 7.4, 150 mM NaCl, 5 mM 
EDTA,  0.05 %  (v/v)  NP-40,  0.25 %  (w/v)  gelatin,  0.02 %  (w/v)  Na-
azide). Staining was visualized with secondary FITC or Oregon Green-
labelled antibodies (Molecular Probes) and nuclei were counterstained 
with DAPI or propidiumiodide. 
Results
Cytoplasmic and nuclear localization of overexpressed  
HA-TAB2
In  our  initial  studies  examining  mTAB2  expression,  we 
observed only low levels of protein in most cells and tis-
sues. To confirm that we were indeed detecting TAB2, to 
verify its molecular weight and to determine its subcellular 
localization, we generated HA-tagged mTAB2 constructs 
that  could  be  used  for  overexpression  studies. Transient 
overexpression of HA-tagged full length and N-terminally 
truncated mTAB2 constructs (Fig. 1A) in 3T3 fibroblast or 
CHO cells was followed by Western blotting to detect the 
HA-tagged proteins. As a positive control for the HA an-
tibody, we used a lysate from cells expressing HA-tagged 
Oct6 protein. As shown in Figure 1B, the protein lysate from 
HA-mTAB2 full length transfected cells yielded a band on 
Western  blot  with  a  molecular  weight  of  approximately 
80 kD, consistent with the expected size of the mTAB2 pro-
tein with the HA-tag (76 kD plus 3 kD). Additionally, over-
expression of the truncated HA-mTAB2C construct yielded 
the expected smaller protein product (approximately 37 kD) 
on Western blot. 
Since the subcellular localization of a protein can pro-
vide an insight into its cellular function, we examined the 
localization of HA-tagged mTAB2 in CHO cells. Previ-
ously, the N-terminal truncated mTAB2C protein was re-
ported to act in a dominant negative manner in the IL-1 and 
TNF signaling pathways [16]. Thus, we examined whether 
the N-terminal truncated and full-length mTAB2 proteins 
were localized to similar cellular compartments. As shown 
in Figure 1C, we found a punctate staining pattern in the 
cytoplasm of mTAB2 overexpressing CHO cells. In some 
overexpressing  cells,  we  also  observed  nuclear  mTAB2 
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staining. No clear difference in subcellular localization was 
observed between the truncated and the full-length mTAB2 
protein. 
mTAB2 protein is expressed in adult mouse tissues
Previously we reported that the TAB2 gene (Map3k7ip2) is 
transcribed in all adult mouse tissues ([24]: see also Fig. 2A). 
To determine whether the mTAB2 protein is expressed simi-
larly, we performed Western blot analysis for mTAB2 using 
cell lysates from adult mouse tissues. We used two com-
mercially available antibodies successfully used by others to 
detect endogenous TAB2 [18, 21]. Both a-TAB2 antibodies 
yielded similar results on Western blots. We detected a pro-
tein band with a molecular weight of approximately 76 kD 
(Fig. 3). Based on the HA-tagged TAB2 protein size (Fig. 
1A), we conclude that the 76 kD band corresponds to TAB2. 
High levels of TAB2 protein are present in the non-hemat-
opoietic tissues – liver, kidney and heart (Fig. 3, top panels). 
A longer exposure of the blot was necessary to obtain bands 
of  similar  intensity  in  the  other  tested  tissues.  Relatively 
lower levels of TAB2 protein are present in hematopoietic 
tissues – BM, spleen and thymus – and the brain and lungs 
(Fig. 3, lower panels). Thus, TAB2 protein is expressed in all 
adult mouse tissues examined.
Fig. 1. HA-mTAB2 overexpression in cell lines. A: Schematic overview 
of the HA-mTAB2 constructs generated and used for overexpression 
studies in cell lines. The protein domains of TAB2 are indicated and 
include an N-terminal CUE domain, a coiled-coil domain and an N-ter-
minal Zinc Finger (ZnF) domain. The TAB2C truncated protein has been 
shown to act as a dominant negative TAB2 mutant protein. B: Western 
blot probed with anti-HA specific antibody shows overexpression of 
HA-TAB2  full  length  (FL)  and  truncated  protein  (TAB2C)  in  3T3 
fibroblasts. These TAB2 constructs express a 78 kD and 37 kD protein 
respectively.  C:  Immunofluorescence  of  transfected  CHO  cells  over-
expressing  HA-tagged  mTAB2  full-length  and  truncated  (mTAB2C) 
protein. DAPI and anti-HA antibody stainings show that mTAB2 protein 
is localized in a punctate pattern in the cytoplasm and nucleus. Original 
magnification 400×. 
Fig. 2. TAK1 and TAB mRNA expression mouse tissues and adult bone 
marrow.
A: Northern blot analysis for TAB2 and TAB3 transcripts in cells from 
several adult mouse tissues and cell lines. B: RT-PCR analysis for TAB1, 
TAB2, TAB3 and TAK1 shows that these genes are expressed in both the 
lineage marker positive (mature hematopoietic cell population) and the 
lineage marker negative (hematopoietic progenitor cell population) of 
the adult mouse bone marrow. The 416B mouse hematopoietic cell line 
is a positive control. RT is reverse transcriptase. 
Fig. 3. TAB2 protein analysis of adult mouse tissue lysates by West-
ern blotting. Western blotting was performed on protein extracts from 
several adult mouse tissues with TAB2 specific antibody from Affinity 
BioReagents. The protein band at 76 kD represents TAB2. The highest 
TAB2 expression (upper panels; 3 h exposure) is found in liver, kidney 
and heart. Relatively lower TAB2 expression (lower panels; 24 h expo-
sure) is found in the hematopoietic organs; bone marrow (BM), thymus 
and spleen and also the brain and lungs. Actin was used as a control for 
protein loading (upper and lower panels; 3 min exposure). Blots were 
probed with anti-TAB2 antibody and then reprobed with an anti-actin 
antibody (not specific for cardiac actin). 
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Table 1. Sleep parameters that are abnormal in chronic inflammatory conditions.
Chronic   Subjective parameters  Objective parameters (PSG)
Inflammatory   Sleep   Frequent   Daytime   NREMS   Sleep   PLMI  RDI  Sao2(min)
Condition  Latency  awakening  sleepiness  (SWS)  latency 
Asthma  +  +  +  +  +   
Rheumatoid   +  +  +  +  +  +   
Arthritis
Systemic   +  +  +  +  +  +  +  + 
Lupus    
Erythematosus 
PSG = (Polysomnography); NREMS = NONREM Sleep; SWS + slow wave sleep; PLM = periodic leg movement; RDI = respiratory disturbance 
index; sao2 (min) = oxygen desaturation 
Localization of TAB2 in adult mouse tissues
To more specifically identify and localize the cells express-
ing TAB2 in adult mouse tissues, we performed immuno-
histochemistry. Cryosections of several adult mouse tissues 
were incubated with TAB2 antibody and staining was visu-
alized with the peroxidase substrate DAB chromogen. For 
these analyses we used the two different TAB2 antibodies 
which both gave similar TAB2 expression patterns in the tis-
sues tested. Sections were counterstained with hematoxylin 
to visualize individual cells and the overall morphology of 
the tissues. 
In coronal adult brain sections, TAB2 is expressed in 
cells scattered throughout the grey matter of the cerebel-
lum. High expression is observed in cells in the outer lay-
ers of the cortex, excluding the outermost layer (Fig. 4B). 
The expressing cortical cells are mainly neuronal and al-
most all these cells express TAB2. The highest percentage 
of TAB2 expressing cells is localized immediately beneath 
the  outermost  layer  of  the  cortex.  Interestingly,  TAB2 
staining overlaps with the nuclear hematoxylin staining 
(Fig. 4C), suggesting that in neuronal cells of the adult 
brain TAB2 protein is predominantly in the nucleus. In ad-
dition, in the midgestation mouse embryo, high TAB2 pro-
tein expression is detected in the dorsal root ganglia, the 
lateral motor column and in nerve tissue near the neural 
tube (Fig. 5).
The spleen is a lymphoid/myeloid tissue that is comprised 
of the white pulp containing mainly lymphocytes and the red 
pulp containing mostly erythrocytes and connective tissue. 
The white pulp is separated from the red pulp by the margin-
al zone, where macrophages are localized. In the spleen, we 
observed TAB2 expression in the endothelium of the blood 
vessels (Fig. 4F, arrow heads), most likely the central arte-
rioles and the trabecular arteries (those vessels containing 
blood cells entering the spleen). No expression was found 
in the sinusoids (where blood cells re-enter circulation). Ex-
pression of TAB2 at lower levels was also observed in small 
mononuclear cells scattered throughout the spleen (Fig. 4E, 
arrows) and in larger granular macrophage-like cells (Fig. 
4E, arrow heads). Most of these TAB2 expressing cells are 
located near blood vessels or at the border of the white and 
red pulp areas, the marginal zone. 
The thymus is also an important lymphoid tissue and 
can  be  morphologically  separated  into  the  outer  cortex, 
which contains less differentiated lymphocytes, and the in-
ner medulla area, which contains more mature differenti-
ated lymphocytes. Similar to the spleen, TAB2 expression 
in the thymus is observed in the endothelium of blood ves-
sels (Fig. 4I, arrow heads). Some cells with the morphol-
ogy of lymphocytes also appear to express low levels of 
TAB2 (Fig. 4H, arrow). Additionally, a low percentage of 
cells scattered throughout both the cortex and the medulla 
regions show TAB2 expression (Fig. 4I, arrow heads). This 
small population of TAB2 expressing cells may represent 
macrophages.
TAB2 expression was also found in the endothelium of 
blood vessels and some bronchioli in the adult lung (low 
levels; data not shown). No TAB2 expression was observed 
throughout the myocardial tissue of the heart, but clear TAB2 
expression was observed in the endothelium of blood ves-
sels and in some cells located near blood vessels (data not 
shown). Due to high levels of background staining in the 
liver and kidney, we could not determine the TAB2 expres-
sion pattern in these tissues. Hence, TAB2 protein is highly 
expressed in endothelial cells lining blood vessels of most 
adult tissues examined. TAB2 is also expressed in neuronal 
cells of the adult brain and in some cells in the lymphoid tis-
sues of the adult, the spleen and thymus. 
Fig. 4. TAB2 is expressed in the adult mouse in neuronal and hemat-
opoietic tissues. Cryo-sections of adult (A–C) brain, (D–F) spleen and 
(G–I) thymus. Sections stained with anti-TAB2 (k-20; Santa Cruz) anti-
body (B, C, E, F, H and I) and negative control sections (no anti-TAB2 
antibody; A, D and G) were all counterstained with hematoxylin. Brain 
TAB2 expression (B) is found in neuronal cells in the outer layers of 
the cerebellum, except for the outermost layer. (C) TAB2 appears to be 
localized to the nuclei of the cells. Spleen TAB2 expression is detected 
in the endothelium of blood vessels (F, arrow heads) and in few scat-
tered cells at the borders of the red and white pulp area and near blood 
vessels (E; arrow head indicates macrophage-like and arrow indicates 
lymphoid-like cells). Thymus TAB2 expression (H and I) is located to 
the endothelium of blood vessels and few scattered cells in both the cor-
tex and medulla (arrow heads indicate macrophage/endothelial-like and 
arrow head indicates lymphoid-like cells). Original 10× magnification 
(A, F, I) and 100× magnification (B, C–E, G and H).
Fig. 5. mTAB2 is expressed in the midgestation neural tube. Immuno-
histochemistry was performed on transversal cryosections of E11.5 em-
bryos with anti-TAB2 antibody. Prominent TAB2 staining is observed in 
the dorsal root ganglia (DRG), the lateral motor column (LMC) and in 
nerve tissue (N) near the neural tube.
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TAB2 is localized in the cytoplasm of adult bone marrow 
and spleen cells
Previously, we reported TAB2 protein expression in the ma-
jor hematopoietic tissues during early mouse development 
(AGM region and fetal liver) [24]. In this study we investi-
gated whether TAB2 is expressed in the bone marrow (BM), 
the main site of hematopoiesis in the adult. We performed 
RT-PCR analysis for TAB1, TAB2 TAB3 and TAK1 expres-
sion on adult BM cells separated into two hematopoietic 
fractions; mature (lineage maker positive) and immature (lin-
eage maker negative) fractions. Expression of all three TAB 
genes and the TAK1gene was observed in both BM fractions   
(Fig. 2). 
Next we examined adult BM populations for TAB2 pro-
tein expression by performing immunofluorescence analysis 
on cytospins of sorted hematopoietic (CD45
+) and non-he-
matopoietic (CD45
–) cells. TAB2 protein is expressed in most 
BM cells (Fig. 4E and F). It is expressed in both CD45
+ (Fig. 
6I and J) and CD45
- (Fig. 6M and N) cells, but it appears 
that the CD45
- fraction expresses higher levels of TAB2. In 
most cells the TAB2 staining appears to be surrounding the 
nuclear propidium iodide stain (Fig. 6E, I and J), indicat-
ing that TAB2 is localized in the cytoplasmic compartment. 
However, it is possible that the higher TAB2 expression in a 
few CD45
- cells (Fig. 6N, arrow) may reflect an additional 
nuclear localization of TAB2. 
Similarly, adult spleen cells unsorted (Fig. 6G and H) 
and sorted in CD45
+ (Fig. 6K and L) and CD45
– (Fig. 6O 
and P) fractions were examined for TAB2 expression. Most 
splenocytes and cells in both the hematopoietic and non-he-
matopoietic fractions expressed TAB2. TAB2 expression ap-
peared to be localized to the cytoplasm and in rare cells, in 
the nucleus (Fig. 6H and P, arrows). Hence, TAB2 protein 
is expressed in adult BM and spleen predominantly in the 
cytoplasmic compartment of most cells.
Discussion
TAB2 expression pattern in the adult mouse
By Western blot analysis, we observed widespread TAB2 
expression, consistent with our results showing widespread 
TAB2 mRNA expression in adult mouse tissues. We have 
shown here that TAB2 protein is expressed in all adult mouse 
tissues tested. Interestingly, in the adult mouse IL-1RI and 
IL-1RII proteins are also expressed widely and at high levels 
in non-hematopoietic tissues and at low levels in lymphoid 
tissues. Although TAK1 has been subject of a few expression 
studies [25, 26], until our study, little was known about TAB 
protein expression patterns.
By  immunostaining,  we  detected  TAB2  expression  in 
most adult tissues – in specific cerebellar locations in the 
brain; in the endothelial cells of blood vessels in the spleen, 
thymus and heart; and in hematopoietic cells of the BM, 
spleen and thymus. Interestingly, the spatial expression pat-
tern of TAB2 in adult mouse tissues shows many similarities 
with the previously reported IL-1R expression pattern [27, 
28] as well as with the reported in vivo NFkB activity pat-
tern [23]. Schmidt-Ullrich et al. analysed a transgenic mouse 
model containing a NFkB-responsive promoter driving ex-
pression of the lacZ reporter gene and showed NFkB activity 
in the adult mouse brain in a scattered pattern in the outer 
layers of the cerebellum. Moreover, the endothelial cells of 
several blood vessels and scattered cells in the spleen and 
thymus were lacZ positive [23]. The expression pattern of 
NFkB activity also shows striking similarities to the TAB2 
expression pattern in the embryo, thus suggesting that TAB2 
expression, IL-1 signaling and NFkB activity in vivo may be 
closely related. [27]. This is supported by our studies in the 
early mouse embryo showing that the TAB2 expression pat-
tern in the dorsal aorta [24] overlaps with the IL-1RI expres-
sion pattern (Orelio et al. submitted). 
The subcellular localization of TAB2 suggests multiple 
functions
To  date, TAB2  was  shown  to  play  a  role  in  vitro  as  an 
adapter protein in the receptor proximal signalling events of 
the pro-inflammatory IL-1 and of several TNF-family mem-
bers. These studies show that TAB2 is involved in the activa-
tion of the NFkB pathway via the binding to ubiquitinated 
Fig. 6. Intracellular TAB2 localization in adult bone marrow cells. Un-
sorted (A–H) and sorted CD45
+ (I–L) and CD45
– (M–P) adult bone mar-
row (A, B, E, F, I, J, M, N) and spleen (C, D, G, H, K, L, O, P) cells 
were prepared as cytospins. Cells were fixed on microscope slides for 
immunofluorescence  staining  with  anti-TAB2  primary  antibody  (Af-
finity BioReagents) and OregonGreen-conjugated secondary antibody 
(E–P) and Propidium Idodide. OregonGreen fluorescence is shown in all 
panels and Propidium Iodide fluorescence (red) is shown in panels as in-
dicated. Control unsorted cells (A–D) were stained only with fluorescent 
secondary antibody and Propidium Iodide. Since very few CD45
- cells 
were obtained from the spleen, two different fields are shown (one field 
in the inset and one in the background). Most bone marrow and spleen 
cells are expressing low levels of TAB2 protein. Cells in the CD45
- frac-
tions are generally expressing higher levels of TAB2. TAB2 is present in 
the cytoplasm of most cells, but may be localized in the nucleus of some 
CD45
- cells (arrows in panels H, N, P). Original magnification 400×. 
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TRAF2 and TRAF6 in the cytoplasm [14–16, 29–31]. More 
recent studies with TAB2 deficient cells (Sanjo et al. 2003; 
Shim et al. 2005) were unable to confirm this crucial role for 
TAB2 in NFkB activation. This is most likely due to redun-
dancy of TAB2 function with its highly homologous family 
member, TAB3 [15, 18, 31]. However, TAB2 deficiency in 
vivo does result in an embryonic lethal phenotype, suggest-
ing that TAB2 plays other important, non-redundant roles 
[19]. Some insight into the other functions of TAB2 was 
provided by TAB2 deficient cells. In these cells it has been 
observed that IL-1 induced NFkB DNA binding activity is 
higher than in wild type cells, suggesting that TAB2 plays 
an inhibiting role in the regulation of NFkB target genes 
[19, 20]. Recent studies have confirmed a crucial role for 
TAB2 in the repression of NFkB-mediated gene regulation 
[21, 22] and have thereby confirmed that TAB2 has crucial 
nuclear function.
In this study we have found both a cytoplasmic and the 
nuclear localization of HA tagged TAB2 in overexpressing 
CHO cells. Preliminary studies examining the subcellular 
localization of endogenous TAB2 protein in cell lines, also 
show  TAB2  protein  localization  in  both  compartments 
(unpublished data). In contrast, our immunostaining data 
presented here shows mainly a cytoplasmic localization of 
endogenous TAB2 expression in most adult BM and spleen 
cells. However, rare cells in the BM (endothelial, myeloid) 
may also contain nuclear TAB2. Thus, careful analysis of 
specific lineages of TAB2 expressing cells in specific tis-
sues is required before it can be concluded whether TAB2 
expression in one or both of the compartments is related to 
different functions in vivo. This will also require knowledge 
of the specific expression pattern of the other TAB family 
members to determine whether there is functional redun-
dancy. 
The TAB2 expression pattern suggests a role in  
inflammatory-related diseases 
The pro-inflammatory cytokine IL-1 has been shown to play 
a role in several inflammatory-related diseases, including 
the neurodegenerative Alzheimer’s disease and in vascular 
diseases such as atherosclerosis [7–9]. More interestingly, 
based on in vitro studies TAB2 has also been suggested 
to play a role in the pathogenesis of Alzheimer’s disease 
by  regulating  NFkB-mediated  gene  regulation  [21].  To 
date, there are still large gaps in our understanding of the 
molecular processes that are playing a role in vivo in the 
pathogenesis of such diseases. Here we show that, similar 
to the IL-1 receptor, the IL-1 signalling component TAB2 
is expressed in the brain and vascular endothelium. Future 
studies examining the co-expression of TAB2, IL-1 and its 
receptor and NFkB activity will determine whether these 
components together play a pivotal role in the normal physi-
ological regulation as well as in the pathogenesis of these 
tissues/cell types. 
Taken together, the expression pattern and subcellular 
localization of TAB2 implicates it as an interesting regula-
tor, perhaps serving different in vivo functions in various cell 
lineages most likely through the IL-1 and NFkB signalling 
pathways. 
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